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http://www.biomedcentral.com/1472-684X/12/43RESEARCH ARTICLE Open AccessPaediatric palliative care: development and pilot
study of a ‘Directory’ of life-limiting conditions
Richard Hain1,2,3*, Mary Devins4, Richard Hastings5 and Jayne Noyes2Abstract
Background: Children’s palliative care services are developing. Rational service development requires sound
epidemiological data that are difficult to obtain owing to ambiguity in the definitions both of the population
who needs palliative care and of palliative care itself. Existing definitions are of trajectory archetypes. The aim of
this study was to develop and pilot a directory of the commonest specific diagnoses that map on to
those archetypes.
Methods: The diagnoses of patients under the care of five children hospices and a tertiary specialist palliative
medicine service in the UK were recorded. Duplicates and diagnoses that were not life-limiting conditions
according to the ACT/RCPCH criteria or were not primary were removed. The resulting Directory of life-limiting
conditions was piloted by analysing Death Certificate data of children in Wales between 2002 and 2007.
Results: 1590 diagnoses from children’s hospices and 105 from specialist palliative medicine were combined.
After removals there were 376 diagnostic label. All ICD10 chapter headings were represented by at least one
condition. The pilot study showed that 569 (54%) deaths in Wales were caused by LLC. Only four LLC resulted in
ten or more deaths. Among deaths from LLC, the ten commonest diagnoses accounted for 32%, while the 136
diagnoses that caused one or two deaths accounted for 25%. The majority occurred from a small number of
life-limiting conditions.
Conclusion: The Directory is a practical tool for identifying most life-limiting conditions using ICD10 codes that
facilitates extraction and analysis of data from existing sources in respect of life-limiting conditions in children such
as death certificate data, offering the potential for rapid and precise studies in paediatric palliative care.
Keywords: Palliative care, Symptom control, Epidemiology, Trajectory, Public healthBackground
The need of children for palliative care is well recog-
nised [1-9] but difficult to define. It is defined by the
needs of an individual child and family when cure is no
longer possible, rather than by age or organ system. The
Royal College of Paediatrics and Child Health (RCPCH),
working with the Association for Children’s Palliative
Care (ACT) in 1997, defined the concept of life-limiting
condition [6] through a series of archetype descriptions
(Table 1), but did not attempt to name specific diagnoses
except as exemplars. If, however, children are to have
the same access to specialist palliative interventions as* Correspondence: oupc0f@bangor.ac.uk
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reproduction in any medium, provided the oradults currently enjoy, service developers must engage
commissioners. That requires a precise understanding of
the numbers of children who need services, which in
turn requires specific diagnostic criteria.
We developed a Directory of life-limiting conditions by
mapping the four ACT/RCPCH archetypes onto the diag-
noses of actual patients admitted to hospice or palliative
care services in the UK. We then piloted the Directory by
using it to interrogate death certificate data for children in
Wales over a five-year period.
We describe development of the Directory and, in the
light of results of the pilot study, consider some of its
current limitations as well as the wider applications in
taking forward service and research developments in
children’s palliative care. The aim of this study was to
develop and pilot a tool that can largely define the groupd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 ACT/RCPCH Categories [6]
Category Key characteristic Description Examples
I Potential for cure - life is threatened,
not necessarily limited.
Conditions for which treatment may be feasible but can fail Cancer
Some cardiac anomalies
II Period of normality despite
having fatal diagnosis.
Conditions where premature death is inevitable but where
there may be long periods of participation in normal activities
Duchenne Muscular Dystrophy
III Relentless deterioration from,
or before, time of diagnosis.
Progressive conditions without curative treatment options,
where treatment is exclusively palliative and commonly
extends over many years
Metabolic or neurodegenerative
conditions
IV Unpredictable course whose
progression is not easily
judged from natural history.
Irreversible but non-progressive conditions causing
likelihood of premature death through complications
Severe cerebral palsy
Traumatic brain injury
Septic brain injury
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facilitate secondary analysis of epidemiological data in
this under-researched field.
Methods
Raw diagnostic data were collected
Diagnoses were obtained from patients under the care
of five children’s hospices that were using a standar-
dised data collection tool developed by Chase Hospice
(Esplen, personal communication 2010), and the Welsh
specialist paediatric palliative medicine service based at
the Children’s Hospital in Cardiff. All had been considered
to be ‘life-limiting’ both by the referring clinician and the
clinician accepting the referral.
The list of diagnostic labels was refined
The list was edited in three ways.
Removal of duplicate diagnoses.
Duplicates occurred when two or more terms were
used to describe the same condition (e.g., trisomy 13
and Patau’s syndrome).
Removal of non-diagnoses.
This included terms that had led to referral, but were
not life limiting conditions in themselves. They
included modes of death (e.g., apnoea), treatments for
the life limiting diagnosis (e.g., tracheostomy) and
conditions that were incidental to the life-limiting
diagnosis (e.g., anaemia).
Removal of diagnoses that were not life-limiting.
For the purposes of this study, a life-limiting diagnosis
was considered to be any condition whose trajectory
could be described by one or more of the
ACT/RCPCH archetypes (Table 1).
ICD10 codes were assigned to each diagnosis
A diagnostic label and code from the International
Classification of Disease (ICD10) was assigned by the
investigators to each diagnosis on the list (apps.who.
int/classifications/apps/icd/icd10online/).The draft directory was piloted using Welsh death
certificate data
The draft Directory was used to interrogate a database
comprising aggregated anonymous death certificate data
for all deaths in Wales between 0 and 19 years between
2002 and 2007, obtained from Public Health Wales Obser-
vatory [10]. LLC that mapped onto one or more of the
ACT/RCPCH archetypes but did not already appear in the
draft Directory, were added to the draft.
This was a secondary analysis of data that were an-
onymous or already in the public domain that formed
part of the My Choices project. Ethical approval for the
project was obtained from the Betsi Cadwaldr NHS
Research Ethics Committee.Results
Development
1590 diagnoses from children’s hospices and 105 from spe-
cialist palliative medicine were combined. 1319 diagnoses
were removed (see Methods section). All ICD10 chapter
headings were represented by at least one condition, show-
ing the range of conditions that can limit life in children.
Pilot study
There were 1052 deaths in childhood in Wales between
2002 and 2007 (Tables 1, 2 and 3). Of these, 569 (54%)
were caused by LLC according to the Directory. Of 382
diagnoses listed causes of death on certificates, 186
(49%) were not LLC according to the Directory.
According to the Directory, Death Certificate data re-
corded 169 deaths from life-limiting conditions (Table 3).
97% of which were accounted for by conditions in only
two ICD10 chapters. Only four LLC resulted in ten or
more deaths (Table 2). Among deaths from LLC, the ten
commonest diagnoses accounted for 32%, while the 136
diagnoses that caused one or two deaths accounted for
25%. The majority occurred from a small number of life-
limiting conditions. Malignancy (25%) and neurological
conditions (21%) were the most frequent.
Table 2 Top five causes of death
Number of deaths Diagnosis ICD10 code
26 Cerebral palsy, unspecified G80.9
22 Malignant neoplasm: Brainstem, brain (unspecified) C71.7, C71.9
15 Acute leukaemia (lymphoblastic, myeloid) C91.0, C92.0
11 Epilepsy, unspecified G40.9
9 Muscular dystrophy G71.0
These are causes of death that are describable by one of more of the ACT/RCPCH categories and therefore considered ‘life-limiting’ conditions.
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Defining the population of children with life-limiting
conditions accurately requires precise diagnoses. The
aim of this study was to develop, and then to pilot, a list
of life-limiting diagnoses in children that can be used for
immediate secondary analysis of existing data.
In children, the term ‘life-limiting condition’ encom-
passes non-malignant as well as malignant conditions and
the range of conditions is wide. LLC in children, especially
in the UK, are conventionally classified by the ACT/
RCPCH system [2,5,7,9], which relies for its validity on as-
sumed commonality among the courses of diseases within
each of four categories. Limited evidence [11] supports
this concept, but the ACT/RCPCH categories as they
stand are too vague to be effective as registration criteria
and need to be supplemented by identifying precise diag-
noses. We are not, of course, the first to recognise the
need for specific data in service development. Lists of life-
limiting conditions have been compiled before, notably by
Knapp (personal communication 2011), Craig [9] and
Feudtner [12,13].
The virtue of the ACT/RCPCH system is that it captures
the diversity of conditions that can limit life; our aim was
to obtain useful precise data without losing that virtue.Table 3 Top eleven diagnoses accounting for three or
more deaths among neonates
Number
of deaths
Diagnosis ICD10
code
60 Birth asphyxia, unspecified P21.9
19 Hypoplasia and dysplasia of lung Q33.6
16 Necrotising enterocolitis of fetus and newborn P77
16 Congenital diaphragmatic hernia Q79.0
10 Edwards’ syndrome, unspecified Q91.3
8 Congenital malformation of heart, unspecified Q24.9
7 Persistent fetal circulation P29.3
4 Congenital renal failure P96.0
4 Hypoplastic left heart syndrome Q23.4
3 Severe birth asphyxia P21.0
3 Patau’s syndrome, unspecified Q91.7
These are causes of death describable by one of more of the ACT/RCPCH
categories and therefore considered ‘life-limiting’ conditions. In total, there
were 169 deaths from 24 diagnoses.For the purposes of this study, a life-limiting condition is
therefore a condition whose trajectory is plausibly de-
scribed by one or more of the ACT/RCPCH archetypes.
Diagnoses that emanated from hospices were not the
same as those from specialist PPM services. Children’s hos-
pices typically offer short respite stays and are often nurse-
led. In contrast, specialist PPM services are based around
availability of specialist medical services. Although the two
populations clearly significantly overlap, they are not pre-
cisely co-terminous [14], and combining them therefore
further expanded the number of diagnoses on the list.
It could be argued that some individual children with
diagnoses that are not life-limiting conditions nevertheless
require care that is, in effect, palliative. Traffic injuries
[15], for example, do not fit an ACT/RCPCH category.
For children with severe injuries that lead to death, how-
ever, PPM services could have a valuable role such as sup-
porting end-of-life discussions in intensive care. Perhaps
this indicates a potential value in extending the ACT/
RCPCH categories to reflect the broader role that might
be played by PPM services.
Conditions such as diabetes and epilepsy are usually in-
curable and often require the same approach and ‘ethos’
as palliative care. There is certainly a risk of drawing an ar-
bitrary distinction between palliative care and what is sim-
ply good clinical practice in children. Nevertheless, those
working in the field recognise a population of children
within this wider group who are at high risk of death dur-
ing childhood, and in whom complex symptom control is
a frequent clinical challenge. It is that population that the
Directory aims to help to identify.
There are inevitable limitations to a study of this na-
ture. The ACT/RCPCH archetypes provide a measure of
objectivity but still rely on a certain degree of subjective
judgment. It is not possible to list every possible LLC in
a Directory: the pilot study enabled us to add some diag-
nostic labels that might otherwise have been missed, but
if the Directory is to remain current there will need
to be a mechanism for adding new diagnoses as they
become apparent.
Publically available data recorded on death certificates
is limited to the principal causes of death. It is possible
that small numbers of children with LLC who died from
incidental causes were not identified in our pilot study.
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distinction between diagnoses and patients. The Directory
lists diagnoses. While it would not be valid to draw conclu-
sions about number of children needing access to palliative
care solely from observations of the number who actually
do so, observations of service use do provide a valid source
of diagnoses, since it is extremely likely (though not cer-
tain) that every important LLC would occur at least once.
Similarly, the Directory is designed simply to provide a tool
for analysing epidemiological data. It would be impossible
to draw conclusions about the numbers of children suffer-
ing from life-limiting conditions from the Directory alone.
Effective use of the Directory relies on applying it to data-
bases that include accurate and detailed recording of
ICD10 diagnostic labels to subheading level.
On the other hand, the Directory was easy to use and en-
abled the authors to interrogate a robust existing database
effectively and immediately. We were able to make some
important observations about LLC as causes of death in in
Wales over a reasonable study period of five years. Most
individual LLC caused only one death over that period and
very few diagnoses (5 in neonates, 7 in older children)
caused it 10 times or more (Tables 1 and 2). At the same
time, nearly one third of deaths were accounted for by only
ten different LLC, confirming clinicians’ impression that,
while the range of possible LLC is wide, it is possible to
identify a relatively small number of diagnoses whose
symptom management should form the core of a specialist
palliative care skillset. Of 420 deaths from LLC outside the
neonatal period, 75% were from conditions other than
cancer. This is higher than in studies that have relied on
reporting by paediatricians [14], suggesting there has been
under-recognition of the life-limiting nature of non-
malignant conditions.
The Directory has a number of immediate practical
applications where the sub-population of children with
LLC needs to be identified within larger groups such as
those with complex chronic disability or other chronic
illness. It can rationally underpin fair admission and re-
ferral criteria for children’s hospice services, and help
evaluate the magnitude of the need for specialist pallia-
tive medicine and palliative care services for children by
institutions within the National Health Service. In coun-
tries such as the USA with a private healthcare system,
the Directory can inform funding decisions among in-
surance companies. It can also facilitate robust govern-
ance and record-keeping by those providing palliative
care, by allowing a definition of palliative care derived
from a standard that has been largely agreed.
The Directory has potentially important applications
for research in paediatric palliative care. To define the
population of children needing palliative care in an es-
sential first step in considering any research question
that impacts specially on that group. The Directory hasalready been used for this purpose in research [16,17] and
service development [18]. Prevalence data, in particular,
are key to rational service development, but for LLC there
is no consistent relationship with incidence. Given the
long natural history of LLC [11], it is usually impractical
to obtain the prospective data needed to establish preva-
lence. The pilot study of the Directory shows that an
agreed list of diagnoses potentially allows immediate sec-
ondary analysis of existing data.
Finally, the Directory can potentially allow critical evalu-
ation of the ACT/RCPCH categories themselves, allowing
amendments and improvements to what has become the
standard definition of what constitutes a ‘life-limiting
condition’.
Conclusions
The authors have compiled a ‘Directory’ of ICD10 diag-
noses, drawing on admissions to children’s hospices on
the one hand, and referrals to specialist paediatric pallia-
tive medicine on the other.
A pilot study of the Directory to analyse death certifi-
cate data showed that it was easy to use and allowed im-
mediate secondary analysis of an established database.
The study showed that around half of all childhood
deaths in the study period were from LLC, thje majority
of LLC are non-malignant, and that the range of LLC
causing death in the neonatal period was markedly nar-
rower than outside it.
By defining a list of precise ICD10 codes that map
onto ACT/RCPCH criteria, for the first time the Direc-
tory allows analysis of existing clinical databases, paving
the way for rapid establishment of prevalence data that
would otherwise have been impractically slow.
No list of LLC based on disease label can ever be ex-
haustive. As new diagnoses become apparent, expansion
will be important and should be the basis for further
studies, which should also attach Read and ACT/
RCPCH categories. While it will therefore continue to
need refinement, the Directory is a key tool for rational
service development in children’s palliative care.
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